Sonoma Pharmaceuticals, Inc. (SNOA): Price and Financial Metrics


Sonoma Pharmaceuticals, Inc. (SNOA): $5.35

0.04 (+0.75%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

SNOA POWR Grades


  • Value is the dimension where SNOA ranks best; there it ranks ahead of 68.35% of US stocks.
  • The strongest trend for SNOA is in Momentum, which has been heading down over the past 33 weeks.
  • SNOA ranks lowest in Stability; there it ranks in the 7th percentile.

SNOA Stock Summary

  • SNOA has a market capitalization of $11,110,602 -- more than approximately only 0.1% of US stocks.
  • Sonoma Pharmaceuticals Inc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than 87.64% of US listed stocks.
  • As for revenue growth, note that SNOA's revenue has grown -17.24% over the past 12 months; that beats the revenue growth of merely 13.34% of US companies in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Sonoma Pharmaceuticals Inc are EIG, PSMT, FHI, EVI, and DORM.
  • Visit SNOA's SEC page to see the company's official filings. To visit the company's web site, go to www.sonomapharma.com.

SNOA Valuation Summary

  • In comparison to the median Healthcare stock, SNOA's price/sales ratio is 78.95% lower, now standing at 0.8.
  • SNOA's price/sales ratio has moved down 20.2 over the prior 177 months.
  • Over the past 177 months, SNOA's EV/EBIT ratio has gone up 2.

Below are key valuation metrics over time for SNOA.

Stock Date P/S P/B P/E EV/EBIT
SNOA 2021-08-31 0.8 2.9 -2.5 -2.8
SNOA 2021-08-30 0.7 2.7 -2.3 -2.6
SNOA 2021-08-27 0.8 2.7 -2.4 -2.7
SNOA 2021-08-26 0.7 2.6 -2.3 -2.6
SNOA 2021-08-25 0.7 2.7 -2.3 -2.6
SNOA 2021-08-24 0.7 2.7 -2.3 -2.6

SNOA Growth Metrics

  • The 4 year net cashflow from operations growth rate now stands at 47.51%.
  • Its 3 year cash and equivalents growth rate is now at -50.61%.
  • Its 5 year net cashflow from operations growth rate is now at 42.74%.
Over the past 52 months, SNOA's revenue has gone up $3,721,000.

The table below shows SNOA's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-06-30 16.546 -2.31 -5.288
2021-03-31 18.629 -3.378 -3.95
2020-12-31 21.051 -5.493 -1.664
2020-09-30 20.793 -7.079 -2.098
2020-06-30 19.992 -7.62 -3.421
2020-06-30 21.479 -7.611 -2.668

SNOA's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • SNOA has a Quality Grade of D, ranking ahead of 20.88% of graded US stocks.
  • SNOA's asset turnover comes in at 1.011 -- ranking 23rd of 677 Pharmaceutical Products stocks.
  • HALO, NAVB, and MNKD are the stocks whose asset turnover ratios are most correlated with SNOA.

The table below shows SNOA's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 1.011 0.348 -0.457
2021-03-31 1.064 0.352 -0.307
2020-12-31 1.210 0.393 -0.153
2020-09-30 1.226 0.405 -0.202
2020-06-30 1.214 0.411 -0.353
2020-06-30 1.305 0.416 -0.272

SNOA Stock Price Chart Interactive Chart >

Price chart for SNOA

SNOA Price/Volume Stats

Current price $5.35 52-week high $15.19
Prev. close $5.31 52-week low $5.18
Day low $5.21 Volume 65,000
Day high $5.40 Avg. volume 890,969
50-day MA $6.14 Dividend yield N/A
200-day MA $7.45 Market Cap 11.19M

Sonoma Pharmaceuticals, Inc. (SNOA) Company Bio


Sonoma Pharmaceuticals, Inc. operates as a pharmaceutical company. The Company develops and markets solutions for the treatment of dermatological conditions and advanced tissue care. Sonoma Pharmaceuticals serves customers worldwide.


SNOA Latest News Stream


Event/Time News Detail
Loading, please wait...

SNOA Latest Social Stream


Loading social stream, please wait...

View Full SNOA Social Stream

Latest SNOA News From Around the Web

Below are the latest news stories about Sonoma Pharmaceuticals Inc that investors may wish to consider to help them evaluate SNOA as an investment opportunity.

Global Wegeners Granulomatosis/Granulomatosis with Polyangiitis Market Report Forecast to 2021-2027 |key players are Genentech, Inc., GlaxoSmithKline plc., Sonoma Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Antares Pharma, Medac Pharma, Inc.,

A newly published report on Wegeners Granulomatosis/Granulomatosis with Polyangiitis Market by Infinity Business Insights forecasts the market to grow at a robust rate. The ears, nose, throat, lungs, and kidneys can all be affected by granulomatosis with polyangiitis. It''s possible

OpenPR | September 1, 2021

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

Good morning!

William White on InvestorPlace | August 20, 2021

Sonoma Pharmaceuticals Reports First Quarter 2022 Financial Results Wire

Sonoma Pharmaceuticals Reports First Quarter 2022 Financial Results Business Wire

Business Wire | August 20, 2021

Why Sonoma Pharmaceuticals Shares Are Trading Lower Today

Sonoma Pharmaceuticals Inc (NASDAQ: SNOA) is trading significantly lower Friday amid possible profit taking after the stock surged Thursday following the company's launch of two new dental products. Sonoma Pharmaceuticals launched OroGenix Oral Hygiene Rinse, which was developed with Gabriel Science and is the company's second dental product in the U.S. OroGenix Oral Hygiene Rinse uses Sonoma’s patented Microcyn technology to cleanse teeth, gums, and mouth. Sonoma and Medical Systems Solutions a

Yahoo | August 20, 2021

What Did the Stock Market Do Today, Aug. 19? 3 Big Stories to Catch Up On.

So what did the stock market do today?

Sarah Smith on InvestorPlace | August 19, 2021

Read More 'SNOA' Stories Here

SNOA Price Returns

1-mo -13.71%
3-mo -29.79%
6-mo -24.65%
1-year -32.28%
3-year -61.65%
5-year -85.54%
YTD -26.31%
2020 66.51%
2019 -31.77%
2018 -86.97%
2017 8.13%
2016 -12.35%

Continue Researching SNOA

Want to see what other sources are saying about Sonoma Pharmaceuticals Inc's financials and stock price? Try the links below:

Sonoma Pharmaceuticals Inc (SNOA) Stock Price | Nasdaq
Sonoma Pharmaceuticals Inc (SNOA) Stock Quote, History and News - Yahoo Finance
Sonoma Pharmaceuticals Inc (SNOA) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 1.1093 seconds.